ClinChoice Acquires CROMSOURCE to Expand CRO Capabilities Globally
ClinChoice has acquired CROMSOURCE to expand their CRO capabilities globally.
anteris Acquired by Kymanox, a Portfolio Company of Westview Capital Partners, to Expand Injectable Combination Product Development Capabilities Globally
Transaction helps both companies realize their shared goals of geographic expansion, while also bolstering service capabilities.
OpenClinica Completes Growth Recapitalization with Thompson Street Capital Partners to Accelerate Enablement of Clinical Trials
The company’s service offerings were the ideal strategic complement to enhance Syner-G’s existing suite of comprehensive CMC solutions.
Clairvest Acquires Boca Biolistics to Accelerate Growth of Infectious Disease and Oncological Biobanking Capabilities
Boca’s high growth profile and differentiated positioning within the biobanking industry made it the ideal acquisition for Clairvest’s ongoing multi-year domain effort in the life sciences industry.
RMC Pharmaceutical Solutions Acquired by Syner-G Biopharma Group, a Portfolio Company of Riverside Partners, to Expand Regulatory Compliance Solutions
The company’s service offerings were the ideal strategic complement to enhance Syner-G’s existing suite of comprehensive CMC solutions.
LongueVue Capital Partners Acquires Majority Stake in Summit Clinical Research to Accelerate SMO/IRO Growth
LongueVue Capital Partners has acquired a majority stake in Summit Clinical Research to accelerate SMO/IRO growth.
Sabai Global Acquired by Thompson Street Capital Partners to Accelerate IBC and IRB Growth
Sabai's specialized services made the Company the ideal target for a strategic growth investment from Thompson Street Capital Partners.
H.I.G. Capital Acquires Majority Stake in Navitas Life Sciences to Accelerate CRO Growth
Lexitas Pharma Services has been acquired by NovaQuest Private Equity to support continued growth and capability expansion.
Lexitas Acquired by NovaQuest to Support Continued Growth and Capability Expansion
Lexitas Pharma Services has been acquired by NovaQuest Private Equity to support continued growth and capability expansion.
CCRC Recapitalized by Martis Capital Via Its Newly Formed Clinical Research Site Platform, Alcanza Clinical Research
Coastal Carolina Research Center has been recapitalized by Martis Capital via its newly formed clinical research site platform, Alcanza Clinical Research.